1. India Stocks

  2. •

    Commercial services

  3. •

    Miscellaneous commercial services
Choksi Laboratories Limited

Choksi Laboratories Limited

BBSE:CHOKSILA
204.95
INR
-4.25
(-2.03%)
3.12EPS
39.77P/E
863.68MMarket Cap
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
28.55
31.55
32.02
41.29
44.79
48.45
40.43
36.88
43.13
49.45
52.68
59.99
66.05
67.54
Basic EPS, GAAP
1.67
1.27
1.04
1.28
1.93
2.3
-5.58
-3.74
0.3
4.61
1.59
2.19
2.82
3.12
Free Cash Flow per Basic Share
-3.49
0.36
-1.1
4.78
1.86
-4.44
-16.05
-3.16
7.2
5.89
6.4
5.87
-0.45
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
29.16
27.73
28.76
30.33
32.15
34.47
29.03
25.48
25.7
30.31
31.89
33.89
36.72
- -
Tangible Book Value per Share
28.64
27.25
28.38
30.01
31.87
34.04
28.83
25.06
25.24
29.74
31.37
33.2
36.12
- -
Basic Weighted Avg Shares
7
7
7
7
7
7
7
7
7
7
7
7
7
7
Sales/Revenue/Turnover
199
220
223
288
312
337
282
257
300
344
367
418
460
468
Operating Margin (%)
13.69
11.23
11.25
8.3
11.15
11.78
-2.82
-1.17
12.19
14.38
12.86
11.99
11.8
11.04
Depreciation Expense
16
28
27
29
32
37
46
46
54
55
57
65
71
74
Net Income, GAAP
12
9
7
9
13
16
-39
-26
2
32
11
15
20
22
Effective Tax Rate (%)
28.43
36.07
36.63
31.84
30.31
30.26
- -
- -
43.6
13.74
33.27
29.26
38.51
31.73
Profit Margin (%)
5.86
4.01
3.24
3.1
4.32
4.74
-13.8
-10.15
0.69
9.32
3.02
3.65
4.27
4.62
Working Capital
11
28
14
-13
-6
28
21
-32
-15
14
-43
-76
-42
- -
LT Debt
63
56
81
43
55
140
293
313
296
252
191
160
212
- -
Total Equity
203
193
200
211
224
240
202
177
179
211
222
236
256
- -
Return on Invested Capital (%)
7.18
6.44
4.84
4.52
6.45
6.54
- -
- -
3.51
11.12
5.71
6.45
6.42
- -
Return on Capital (%)
7.1
6.48
4.57
5.6
7.28
6.99
- -
- -
3.6
11.45
5.85
6.43
6.58
- -
Return on Common Equity (%)
5.95
4.45
3.67
4.34
6.19
6.9
-17.57
-13.74
1.16
16.46
5.12
6.65
7.99
- -

Capital Structure

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
ST Debt
- -
130
- -
LT Borrowings
- -
178
- -
LT Finance Leases
- -
34
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
7
7
7
Market Capitalization
900
722
864

Working Capital

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
Total Current Assets
- -
189
- -
Cash, Cash Equivalents & STI
- -
4
- -
Accounts Receivable, Net
- -
147
- -
Inventories
- -
2
- -
Total Current Liabilities
- -
231
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
130
- -
Deferred Revenue
- -
- -
- -

Growth Rates

INR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
2.93%
7.73%
8.35%
Free Cash Flow
-120.82%
-90.69%
-107.62%
Net Income, GAAP
106.13%
268.71%
28.95%
Sales/Revenue/Turnover
8.24%
12.42%
10.11%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
107
93
104
114
418
2026
112
111
108
128
460
2027
121
- -
- -
- -
- -

Quarterly Earnings Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
0.6
0.11
0.15
1.32
2.19
2026
0.55
0.35
0.45
1.47
2.82
2027
0.84
- -
- -
- -
- -

Quarterly Dividends Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
2027
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Sunil Kumar Choksi
Full Time Employees
364
Sector
Commercial services
Industry
Miscellaneous commercial services
Address
Survey No. 9/1 Indore MP India 453555
IPO Date
Jun 13, 1994
Website
choksilab.com
Similar Companies
PayPal Holdings, Inc. (NASDAQ:PYPL)
Shopify Inc. (NASDAQ:SHOP)
Greenland Mines Ltd (NASDAQ:GRML)
Block, Inc. (NYSE:XYZ)
Netcapital Inc. (NASDAQ:NCPL)
Shopify, Inc. Class A (TSX:SHOP)
Business
Choksi Laboratories Limited operates as a contract research organization primarily engaged in providing comprehensive analytical testing and research services across India and internationally. The company offers a wide range of core products and services including contract laboratory services with pharmaceutical analysis, food and beverages testing, water and soil analysis, chemical and dyes testing, cosmetics evaluation, and construction material analysis. It also provides instrument calibration and validation services such as laboratory and on-site calibration for test equipment, process equipment, end-user equipment, plant shutdown calibration, and consultancy for setting up in-house calibration labs. Additional service offerings encompass environment management including waste disposal, effluent treatment, air pollution monitoring, and wastewater management; clinical research services with bioavailability and bioequivalence studies; and consultancy services covering training, third-party inspections, and auditing. The company also conducts assaying and hallmarking services for precious metals like gold and silver. Choksi Laboratories serves key industries including pharmaceuticals, consumer products, engineering, and agrochemicals. Founded in 1982 and headquartered in Indore, India, the company operates multiple laboratories and employs over 450 personnel. Recently, Choksi Laboratories received enhanced approval from the Central Drugs Standard Control Organization (CDSCO) for the expanded testing and quality assessment of medical devices, reinforcing its commitment to regulatory compliance and high standards in healthcare testing. The company also entered into an agreement with the Bihar State Milk Co-operative Federation Limited to set up a laboratory for testing milk and milk products under a national dairy development program, highlighting its expansion in the food testing domain. Financially, it reported a steady revenue growth with net sales of Rs 11.40 crore in March 2025, reflecting ongoing operational stability. The company continues to develop its service portfolio in line with regulatory requirements and industry needs, maintaining leadership in analytical and testing services within its sectors of operation.